Serendipitous crossed aldol reaction in the second coordination sphere of a Ru(II) polypyridyl complex in silica bed: prospect for delivering anticancer agents for photoactivated chemotherapy

Ramranjan Mishra,Pritha Chatterjee,R. J. Butcher,Ashis Kumar Patra

DOI: https://doi.org/10.1039/d4dt02337d

IF: 4

2024-10-20

Dalton Transactions

Abstract:The localized drug action in tumors to overcome the side effects of chemotherapy became an impetus for the development of photoactivated chemotherapy (PACT). As potential PACT agents, ruthenium(II) polypyridyl complexes have emerged as efficient photocages for anticancer agents. Bioactive molecules possessing functional groups such as nitrile, thioether, pyridine, imidazole, etc. are often directly attached in the primary coordination sphere of Ru(II) polypyridyl complexes for this purpose. Herein, we propose an alternative design strategy to attach potential anticancer agents lacking in these functional groups with Ru(II) polypyridyl complexes through a pyridyl linker moiety. The proposition is however, a thoughtful extrapolation of a serendipitous crossed aldol reaction that took place between the Ru(II)-coordinated 4-pyridine carboxaldehyde (4-pyCHO) and acetone, discovered while the Ru(II)-complex, [Ru(ttp)(dppz)((4-PyCHO)] 2+ {[ 1 ]} [ttp = p-tolyl terpyridine, dppz = dipyrido[3,2-a:2′,3′-c]phenazine, 4-PyCHO = 4-pyridine carboxaldehyde] was being purified by silica gel column chromatography with acetone/water/saturated aqueous KNO3 solution as eluent. The resultant pure aldol product [Ru(ttp)(dppz)((4-PyCHAc)] 2+ {[ 1-Ac ]} [4-PyCHAc = aldol modified 4-pyridine carboxaldehyde i.e. 4-hydroxy-4-(pyridin-4-yl)butan-2-one)], was unambiguously characterized by a variety of spectroscopic techniques and X-ray crystallography. Furthermore, 1H NMR study after 470 nm light irradiation and subsequent ESI-MS analysis revealed that 4-PyCHO could be photo-released from [ 1-Ac ] as its in situ generated aldol adduct 4-PyCHAc. Therefore, this finding works as a proof-of-concept that provides a simpler alternative design strategy for appending cancer-selective agents having carbonyl groups with α-hydrogens with ruthenium(II) polypyridyl complexes, and their photorelease for selective and targeted anticancer chemotherapy.

chemistry, inorganic & nuclear